Denis joined atai Life Sciences in 2022.
Previously Denis was an Investment Director at Andera Partners where he led due diligence and managed investments in the biotechnology and medical sectors.
Prior to that he worked as an analyst at Michel Dyens & Co. where he worked on several licensing and M&A transactions for early-stage biotechnology companies.
Denis holds a MSc. in Biotechnology Engineering fromSup’Biotech, and a Msc. in Biopharmaceutical management fromESCP Europe.